OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Endocrinology is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)

Article	Citations
Obesity: global epidemiology and pathogenesis	1709
Gut microbial metabolites in obesity, NAFLD and T2DM	586
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification	315
Circadian clocks and insulin resistance	296
Rethinking mechanisms, diagnosis and management of endometriosis	284
Physical activity and muscle–brain crosstalk	279
The human stress response	278
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus	267
The endocrine function of adipose tissues in health and cardiometabolic disease	258
Function and mechanisms of enteroendocrine cells and gut hormones in metabolism	247
The obese adipose tissue microenvironment in cancer development and progression	247
The circadian regulation of food intake	187
The role of hypoxia-inducible factors in metabolic diseases	180
The heterogeneous pathogenesis of type 1 diabetes mellitus	175
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases	161
Geographic influences in the global rise of thyroid cancer	153
Circadian rhythms and exercise — re-setting the clock in metabolic disease	144
Inter-tissue communication in cancer cachexia	138
A road map for understanding molecular and genetic determinants of osteoporosis	134
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs	130
Melatonin in type 2 diabetes mellitus and obesity	130
The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities	127
The clinical potential of circulating microRNAs in obesity	120
Microbiota and metabolites in metabolic diseases	119
The role of osteoblasts in energy homeostasis	115
Turner syndrome: mechanisms and management	114
Sperm RNA code programmes the metabolic health of offspring	113
Post-transplant diabetes mellitus in patients with solid organ transplants	105
Deiodinases and their intricate role in thyroid hormone homeostasis	105
The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state	105
Endocrine disruptors and the future of toxicology testing — lessons from CLARITY–BPA	105
Prolactin — a pleiotropic factor in health and disease	99
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy	99
Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity	94
The role of thyroglobulin in thyroid hormonogenesis	92
Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus	90
Fracture prediction, imaging and screening in osteoporosis	86
Interconnection between circadian clocks and thyroid function	84
From conception to infancy — early risk factors for childhood obesity	80
Mechanisms of weight regain after weight loss — the role of adipose tissue	76
The blood–brain barrier as an endocrine tissue	71
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases	71
Adrenal function and dysfunction in critically ill patients	67
Adrenocortical carcinoma — towards genomics guided clinical care	65
Inhibiting PCSK9 — biology beyond LDL control	65
The effects of growth hormone on adipose tissue: old observations, new mechanisms	62
The arrival of circadian medicine	61
Obesity: a neuroimmunometabolic perspective	60